Rheumatoid arthritis

COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic

Clin Exp RheumatolPublished Retrospective cohort study

Authors' conclusion

COVID-19 was higher in females, younger patients, those with comorbidities, and those using advanced therapies. Compared to pre-pandemic, higher death rates during the pandemic were associated with older age, oral steroid use, smoking, and higher disease activity.

Study context

Population
Rheumatoid arthritis (RA) patients from the Ontario Best Practices Research Initiative (OBRI) linked to Ontario healthcare records (Institute for Clinical Evaluative Sciences (ICES)), January 1st 2020 to March 31st 2022
Participants
2,969 patients
Exposure
RA patients with vs without COVID-19; all-cause mortality before vs after the pandemic
  • COVID-19n = 596
Outcome
COVID-19 prevalence, hospitalisation, ED visits, and impact of RA treatment and baseline characteristics on mortality
Methodological detailslinked registry and administrative healthcare data
  • Linked registry and administrative healthcare data

Main finding

As reported in the abstract

COVID-19 prevalence

COVID-19

20.1%

596

Observational data: associations, not effects.

Further findings

Female sex and COVID-19 infection (81.9% vs. 76.5%)

aOR (95% CI)
Females1.30 (1.01–1.66)

Biologic use and COVID-19 (52.5% vs. 46.1%)

aOR (95% CI)
Biologics1.28 (1.04–1.57)

Janus Kinase inhibitors (JAKi) use and COVID-19 (13.4% vs. 9.5%)

aOR (95% CI)
JAKi1.44 (1.08–1.93)

All-cause mortality, before and after the COVID-19 pandemic

aHR (95% CI)
Older age (>80 years)Stronger associations after the pandemic10.9 (6.49–18.2)
SmokingStronger associations after the pandemic1.85 (1.41–2.42)
Higher disease activity scoreStronger associations after the pandemic1.09 (1.00–1.18)

All-cause mortality before the pandemic, JAKi

aHR (95% CI)
JAKi0.55 (0.34–0.91)

Hospitalised or visited emergency department (ED), among those with COVID-19

Hospitalised or visited ED
108 (18.1%)

Original publication

COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic. Clin Exp Rheumatol. Published 25 March 2025. doi:10.55563/clinexprheumatol/00jq99

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.